HRS-AKI in Liver Transplant Patients: Clinical Perspectives on the Future of Care

Tuesday, June 7, 2022

12:45 pm – 1:45 pm  EDT
 

Sheraton Hotel | 39 Dalton St | ROOM: Back Bay A, B, C | Boston, Massachusetts

Hybrid
CME
swoosh
swoosh

OVERVIEW

Hepatorenal syndrome(HRS) is a complication of cirrhosis and end-stage liver disease that develops in 8% to 12% of adults each year. HRS-acute kidney injury (HRS-AKI) can be distinguished from other forms of AKI by the absence of signs of intrinsic kidney disease. Short-term therapeutic goals are to reverse AKI and prolong survival. However, even with guideline-based treatment, the mortality rate for patients hospitalized with HRS-AKI is > 40%, and long-term survival is very poor without liver transplantation. Early recognition and treatment of HRS-AKI are essential for optimizing both short-term and long-term outcomes for patients with end-stage liver disease.  Join our panel of top experts for this MedscapeLIVE! interactive CME-certified symposium focused on the effective management of patients with HRS-AKI, including the importance of early detection of HRS-AKI, and treatment strategies for HRS-AKI in liver transplant patients. [bold]You must be registered for the American Transplant Congress 2022 to attend this symposium.[/bold]

FACULTY

AGENDA

TARGET AUDIENCE

This activity is intended for transplant surgeons, nephrologists, and gastroenterologists, and other healthcare practitioners (HCPs) who work with patients with end-stage liver disease (ESLD).

GOAL STATEMENT

The goal of this activity is that learners will be better able to recognize and manage HRS-AKI in the pre-liver transplant stage.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST] [ITEM]Considerations for dialysis in patients with HRS-AKI[ITEM]Patient specific considerations for vasoconstrictor therapy[/LIST] Have greater competence related to[LIST][ITEM]Recognizing HRS-AKI early in the disease course[ITEM]Individualizing fluid management for patients with HRS-AKI[/LIST]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]

[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic]AMA PRA Category 1 Credits[/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Sheraton Hotel

39 Dalton St  ROOM: Back Bay A, B, C
Boston, Massachusetts, 02199
United States